Journal of Clinical and Translational Hepatology (JCTH) publishes high quality,
peer-reviewed studies in the translational and clinical human health sciences of liver
diseases. JCTH has established high standards for publication of original
research characterized by a study’s novelty, quality, and ethical conduct in
the scientific process, as well as in the communication of the research
findings. Each issue includes review articles by leading authorities on topics
in hepatology that are germane to the most current challenges in the field.
Special features include reports on the latest advances in drug
development and technology that are relevant to liver diseases. Regular
features of JCTH also include editorials, correspondence, and invited
commentaries on rapidly progressing areas in hepatology. All articles published
by JCTH, both solicited and unsolicited, must pass a rigorous peer review.
publishing model of JCTH avails an international readership, prompting
worldwide interest from contributing authors, and helping promote the diverse
range of hepatology topics covered in our journal. JCTH welcomes
submissions of articles within its topical scope including:
- Novel discoveries in translational and clinical hepatology
- Liver disease mechanisms
- Novel techniques in research and management of liver diseases
- Epidemiological/environmental factors of liver diseases
- Role of immune system function in liver diseases
- Acute and chronic hepatitis
- Genetic and metabolic liver diseases and their complications
- Hepatobiliary diseases
- Liver cancer
- Drug metabolism
- Biliary disease
- Peritoneal tuberculosis
Prof. George Y. Wu
is responsible for the scientific quality of publications.
JCTH is currently indexed in Science Citation Index Expanded (SCIE) , PubMed and Scopus.
JCTH is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc.